4.5 Article

EGFR Somatic Mutations in Lung Tumors: Radon Exposure and Passive Smoking in Former- and Never-Smoking US Women

Journal

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Volume 21, Issue 6, Pages 988-992

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-12-0166

Keywords

-

Funding

  1. NIH
  2. NCI
  3. CCR
  4. Mayo Foundation
  5. Mayo Clinic Cancer Center
  6. Center for Individualized Medicine
  7. NIH [CA-77118, CA-80127]
  8. Japanese Ministry of Health, Labour and Welfare (MHLW)
  9. U.S. Department of Energy (DOE) [DE-HS0000031]

Ask authors/readers for more resources

Background: Patients with lung cancer with mutations in EGF receptor (EGFR) tyrosine kinase have improved prognosis when treated with EGFR inhibitors. We hypothesized that EGFR mutations may be related to residential radon or passive tobacco smoke. Methods: This hypothesis was investigated by analyzing EGFR mutations in 70 lung tumors from a population of never and long-term former female smokers from Missouri with detailed exposure assessments. The relationship with passive smoking was also examined in never-smoking female lung cancer cases from the Mayo clinic. Results: Overall, the frequency of EGFR mutation was 41% [95% confidence interval (Cl), 32%-49%[. Neither radon nor passive-smoking exposure was consistently associated with EGFR mutations in lung tumors. Conclusions: The results suggest that EGFR mutations are common in female, never-smoking lung cancer cases from the United States, and EGFR mutations are unlikely due to exposure to radon or passive smoking. Cancer Epidemiol Biomarkers Prey; 21(6); 988-92. (C) 2012 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available